Experience with cervical Pap smears at the University Hospital in Jeddah [3]

Annals of Saudi Medicine

Volumn 23, Issue 3-4, 2003, Pages 229-231

  Mansoor, Ibrahim ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER GRADING; CANCER MORTALITY; CANCER RISK; CANCER STATISTICS; CARCINOMA IN SITU; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; HUMAN; LETTER; MASS SCREENING; PAPANICOLAOU TEST; PRECANCER; PREVALENCE; PRIORITY JOURNAL; SAUDI ARABIA; SEXUAL BEHAVIOR; UNIVERSITY HOSPITAL; UTERINE CERVIX CYTOLOGY; UTERUS CARCINOMA;

EID: 0042385041     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.2003.229     Document Type: Letter

References (8)

1. Papaicolaou GN, Traut H. The diagnostic value of vaginal smears in carcinoma of the uterus. Am J Obstet Gynecol 1941;42:193-195.
2. Miller BA, Kolonel LN, Bernstein L, Young Jr JL, Swanson GM, West D, Key CR, Liff JM, Glover CS, Alexander GA, at al. Racial/Ethnic Patterns of Cancer in the United States 1988-1992, National Cancer Institue. NIH Pub.No. 96-4104. Bethesda, MD, 1996. pp. 12-20.
3. Crum CP, et al. Pathology of Early Cervical Neoplasia.New York, Churchill Livingstone, 1996.
4. Cancer incidence in Saudi Arabia, by the National Cancer Registry 1994 Report p. 12.
5. Altaf FJ. Pattern of cervical smear cytology in the western region of Saudi Arabia. Ann Saud Med 2001;21:94-6..
6. Blaustein's Pathology of the Female Genital Tract. Fourth Edition, 1994, Springer-Verlag. p. 287.
7. Kurman RJ, Solomon D. The Bethesda system for reporting cervical/vaginal cytology, diagnosis, definitions, criteria and explanatory notes for terminology and specimen adequacy. New York: Spinger-Verlag, 1993
8. Schiffman M et al. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA 2000;283:87-93.